Lataa...

Radiation dermatitis in patients treated with concurrent trastuzumab emtansine (T-DM1)

Trastuzumab Emtansine (T-DM1) improves outcomes for patients with HER2+ breast cancer, and is given concurrently with radiation. We have noted increased radiation dermatitis in these patients, which may have been underreported on the KATHERINE clinical trial, and call for clinicians to remain vigila...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Transl Radiat Oncol
Päätekijät: Corbin, Kimberly S., Breen, William G., Strauss, Jonathan B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369349/
https://ncbi.nlm.nih.gov/pubmed/32715108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2020.06.013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!